Thank you for your interest in our featured speaker podcast by Friends of Cancer Research!

Hear Mark Stewart's podcast, Target the Tumor Mutational Burden and Pursue Harmonization

Friends aims to better understand the impact of assay variation on clinical outcomes, align standards, and define best practices for TMB assessment. Listen as Dr. Mark Stewart discusses the role of the tumor mutational burden (TMB) in cancer research and the need for harmonization throughout the process. 

Friends of Cancer Research 

Listen Now
Audio via SoundCloud.

Mark Stewart leads Friends’ research and policy agenda and oversees research projects. He also establishes partnerships to develop policy proposals and consensus-driven solutions, and accelerate drug development. Mark received his PhD in cancer biology from the University of Alabama at Birmingham.

Get more information and guides by visiting Tumor Mutational Burden and our video gallery.

Related Content